VACH

Voyager Acquisition Corp

Apr 02 • 04:00PM ET

12.33

+0.70 6.02 %

Financial • Shell Companies • USA • NASD

Index	-	P/E	43.38	EPS (ttm)	0.28	Insider Own	-	Shs Outstand	25.30M	Perf Week	0.98%
Market Cap	389.94M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	25.30M	Perf Month	15.45%
Enterprise Value	389.76M	PEG	-	EPS next Q	-	Inst Own	83.61%	Short Float	0.08%	Perf Quarter	15.56%
Income	8.99M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.16	Perf Half Y	17.99%
Sales	0.00M	P/B	1.52	EPS next Y	-	ROA	3.39%	Short Interest	0.02M	Perf YTD	15.56%
Book/sh	8.12	P/C	2166.33	EPS next 5Y	-	ROE	3.56%	52W High	15.68 -21.36%	Perf Year	20.88%
Cash/sh	0.01	P/FCF	-	EPS past 3/5Y	- -	ROIC	3.50%	52W Low	9.24 33.44%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	14.75% 13.61%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	117.11%	Oper. Margin	-	ATR (14)	1.32	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.15	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	57.37	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.15	EPS Q/Q	-41.67%	SMA20	7.79%	Beta	-0.37	Target Price	-
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	-	SMA50	12.31%	Rel Volume	0.12	Prev Close	11.63
Employees	3	LT Debt/Eq	0.00	Earnings	-	SMA200	16.31%	Avg Volume	126.95K	Price	12.33
IPO	Sep 30, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	15,449	Change	6.02%

Mar-13-26 06:00AM	Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG (GlobeNewswire)
Mar-11-26 06:00AM	Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG (GlobeNewswire) +14.68%
Jul-17-25 08:55AM	VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC (GlobeNewswire)
May-29-25 06:34PM	VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform (GlobeNewswire)
May-20-25 12:10PM	VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer (GlobeNewswire)
12:59PM	Loading…
May-05-25 12:59PM	VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program (GlobeNewswire)
Apr-23-25 01:09AM	VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies (GlobeNewswire)

Voyager Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on December 19, 2023 and is headquartered in Brooklyn, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VACH

Voyager Acquisition Corp

Upgrade your Finviz experience